681808-85-5Relevant academic research and scientific papers
Substituted cycloalkyl P1' hepatitis C virus inhibitors
-
Page/Page column 60, (2010/02/06)
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
